<html>
 <head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 </head>
 <body>
  <p>
  </p>
  <p style="text-align: center; background: white; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Calibri', serif;" align="center">
   <a name="_top" href="">
   </a>
   <img src="https://meltwater-apps-production.s3.amazonaws.com/uploads/images/57ffea234e5a197ebe5e8593/blobid8_1485798306200.png" width="770" height="96"/>
  </p>
  <div style="background: white; margin: 0cm 0cm 0.0001pt; font-size: 12pt; font-family: 'Calibri', serif;">
   <span style="font-size: 16.0pt; font-family: 'Calibri',sans-serif; color: black;">
    <span style="font-size: 16.0pt; font-family: 'Calibri',sans-serif; color: black;">
    </span>
   </span>
   <div style="border: none; border-bottom: solid windowtext 1.0pt; padding: 0in 0in 1.0pt 0in;">
    <p style="text-align: center; border: none; padding: 0in; margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
     <strong>
      <span style="font-size: 16.0pt;">
      </span>
     </strong>
    </p>
   </div>
   <p style="text-align: center; margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
    <strong>
    </strong>
   </p>
  </div>
  <div style="border: none; border-bottom: solid windowtext 1.0pt; padding: 0in 0in 1.0pt 0in;">
   <p style="text-align: center; border: none; padding: 0in; margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
    <strong>
     <span style="font-size: 16.0pt;">
      No Embargo
     </span>
    </strong>
   </p>
  </div>
  <p style="text-align: center; margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <strong>
   </strong>
  </p>
  <p style="text-align: center; margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;" align="center">
   <strong>
    <span style="font-size: 14.0pt;">
     Clinical trial informed consent quality similar in developed, developing countries
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <img src="https://meltwater-apps-production.s3.amazonaws.com/uploads/images/57ffea234e5a197ebe5e8593/blobid0_1486410214988.jpg" width="329" height="271" align="left" hspace="12"/>
   <span style="font-size: 14.0pt;">
    Making sure that participants of a clinical trial
 provide informed consent—understanding their role, along with any risks and benefits of voluntary participation—is a cornerstone of ethical trials. Now, researchers reporting in
    <em>
     PLOS Neglected Tropical Diseases
    </em>
    have, for the first time, directly compared the quality of the informed consent process in a developed and a developing country in similar clinical trials of the same hookworm vaccine.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Informed consent depends on five necessary criteria: the willingness to participate, the capacity to make a decision, disclosure of information, comprehension, and the decision to participate. Research conducted in developing
 countries is often thought to have weaker informed consent due to limited education and healthcare access in those countries, but few studies have delved into this.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    In the new work, David Diemert, of the George Washington University School of Medicine and Health Sciences, Flávia Gazzinelli of the Federal University of Minas Gerais, and colleagues used a 32-question survey to assess the
 quality of informed consent in Phase 1 trials of a hookworm vaccine that were being conducted in two locations in Brazil—one rural and one urban—as well as the United States. 105 participants completed the questionnaire, which asked about their understanding
 of the study as well as their reasons for participating.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Overall, there were few statistically significant differences between participants in urban Belo Horizonte, Brazil and Washington, DC, but more differences between people in those locations and in rural, resource-limited Americaninhas,
 Brazil. Knowledge about the trial was poor in all places, with the mean number of correct answers about the study being 45.6% in Americaninhas, 65.2% in Belo Horizonte, and 59.1% in Washington, DC. And while around 40% of participants in Belo Horizonte and
 Washington, DC, had doubts about participating, only 1.5% has concerns in Americaninhas. Moreover, most people in Washington, DC, and Belo Horizonte cited helping others and benefiting the world as major reasons to participate, while most in Americaninhas
 said it was a personal decision, or they wanted to benefit their own health.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    “Based on our results, we conclude that the use of the terms “developed” and “developing” to describe countries is a reductionist exercise to define participants as vulnerable, whereas a rigorous consideration of the specific
 characteristics of each group of individuals recruited as participants in a clinical trial is necessary,” the researchers say. “These findings also demonstrate the need for educational interventions directed at clinical trial participants, both in developing
 and developed countries, in order to improve understanding of the informed consent document.”
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; font-family: 'Calibri',sans-serif; color: black; background: white;">
     In your coverage please use this URL to provide access to the freely available article in
    </span>
   </strong>
   <strong>
    <span style="font-size: 14.0pt; color: black; background: white;">
    </span>
   </strong>
   <em>
    <strong>
     <span style="font-size: 14.0pt; font-family: 'Calibri',sans-serif; color: black; background: white;">
      PLOS
 Neglected Tropical Diseases
     </span>
    </strong>
   </em>
   <strong>
    <span style="font-size: 14.0pt; font-family: 'Calibri',sans-serif; color: black; background: white;">
     :
    </span>
   </strong>
   <strong>
    <span style="font-size: 14.0pt; font-family: 'Calibri',sans-serif; color: black; background: white; font-weight: normal;">
     <a style="color: #0563c1; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=http%3A%2F%2Fjournals.plos.org%2Fplosntds%2Farticle%3Fid%3D10.1371%2Fjournal.pntd.0005327&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=zt3_dka56qnnxo0ybhl5TLpsufHBe0w_E_p1bonDkfA">
      http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0005327
     </a>
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt;">
     Contact:
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    David Diemert
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; background: white;">
    George Washington University School of Medicine and Health Sciences
   </span>
   <span style="font-size: 14.0pt;">
    <br/>
    <span style="background: white;">
     Department of Microbiology, Immunology and Tropical Medicine
    </span>
    <br/>
    <span style="background: white;">
     2300 Eye Street NW
    </span>
    <br/>
    <span style="background: white;">
     Ross Hall 524
    </span>
    <br/>
    <span style="background: white;">
     WASHINGTON, DC 20037, United States
    </span>
    <br/>
    <span style="background: white;">
     Telephone: 202.994.2909
    </span>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; background: white;">
    Email:
   </span>
   <span style="font-size: 14.0pt;">
    <a style="color: #0563c1; text-decoration: underline;" href="mailto:ddiemert@gwu.edu">
     <span style="background: white;">
      ddiemert@gwu.edu
     </span>
    </a>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: #000033; background: white;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: #000033; background: white;">
     Citation:
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt; color: #000033; background: white;">
    Diemert DJ, Lobato L, Styczynski A, Zumer M, Soares A, Gazzinelli MF (2017) A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted
 in Developed and Developing Countries. PLoS Negl Trop Dis 11(1): e0005327. doi:10.1371/journal.pntd.0005327
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: #000033; background: white;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt;">
     Image Credit:
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Flickr user blakespot, Flickr
    <br/>
    <br/>
    <strong>
     Image Caption::
    </strong>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    Physician inoculates patient, hopefully after receiving informed consent
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: #000033; background: white;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt; color: #000033; background: white;">
     Funding:
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    DJD, MZ, and MFG received support for the work reported herein from the Albert B. Sabin Vaccine Institute through grants from the Bill & Melinda Gates Foundation (Grant OPP1016395) and the Ministry of Foreign Affairs of The
 Netherlands (Project Number 23386). LL, ASo and MFG received funding from the Brazilian Federal Agency of Coordination for the Improvement of Higher Education (CAPES) and the National Council for Scientific and Technological Development (CNPq). The funders
 had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt;">
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <strong>
    <span style="font-size: 14.0pt;">
     Competing Interests:
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    The authors have declared that no competing interests exist.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 11pt; font-family: Calibri, sans-serif;">
   <span style="font-size: 14.0pt;">
    <a style="color: #0563c1; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=..%2Foutreach%2Fcompose%2F588f7ba72a0587cea8066baf%2Fduplicate%3Fstep%3D1%23_top&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=Y23cILvuRCzguzFEjv4BIFrqmyFIFsni4lCtgmETzyo">
     <span style="background: white;">
      Back
 to the Top
     </span>
    </a>
   </span>
   <span style="font-size: 14.0pt;">
    <br/>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-size: 10.0pt; font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-size: 11.0pt; font-family: 'Calibri',sans-serif; color: red;">
   </span>
  </p>
  <div style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <hr align="left" size="2" width="100%"/>
  </div>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-size: 10.0pt; font-family: 'Calibri',sans-serif;">
    <br/>
   </span>
   <strong>
    <span style="font-family: 'Calibri',sans-serif;">
     About
     <em>
      PLOS Neglected Tropical Diseases
     </em>
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <em>
    <span style="font-family: 'Calibri',sans-serif; color: #211f20; background: white;">
     PLOS Neglected Tropical Diseases,
    </span>
   </em>
   <span style="font-family: 'Calibri',sans-serif; color: #211f20; background: white;">
    the first journal solely devoted to chronic and poverty-promoting infectious diseases affecting the world’s poorest populations, publishes rigorously peer-reviewed
 research on all scientific, medical, political and public health aspects of NTDs. Commentary on wide ranging topics – from policy discussion to clinical education and topical debates – keep readers current on the implications of research discoveries.
   </span>
   <span style="font-family: 'Calibri',sans-serif; color: #211f20; background: white;">
    For
   </span>
   <span style="font-family: 'Calibri',sans-serif;">
    more information, visit
   </span>
   <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=http%3A%2F%2Fjournals.plos.org%2Fplosntds&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=gp6nNz2Fwv87FdX4coAXQqFNWLBmc7z5AwwzgCwquDg">
    <span style="font-family: 'Calibri',sans-serif;">
     http://journals.plos.org/plosntds
    </span>
   </a>
   <span style="font-family: 'Calibri',sans-serif;">
    ,
 and follow @PLOSNTDs on Twitter.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <strong>
    <span style="font-family: 'Calibri',sans-serif;">
     Media and Copyright Information
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
    For information about
    <em>
     PLOS Neglected Tropical Diseases
    </em>
    relevant to journalists, bloggers and press officers, including details of our press release process and embargo policy, visit
   </span>
   <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=http%3A%2F%2Fjournals.plos.org%2Fplosntds%2Fs%2Fpress-and-media&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=Ezwol0hn6IH1UJI5BHxttjuUcVRZQ1TjdP4B22OebQM">
    <span style="font-family: 'Calibri',sans-serif;">
     http://journals.plos.org/plosntds/s/press-and-media
    </span>
   </a>
   <span style="font-family: 'Calibri',sans-serif;">
    .
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
    PLOS journals publish under a
   </span>
   <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=https%3A%2F%2Fcreativecommons.org%2Flicenses%2Fby%2F4.0%2F&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=Dt1dMGFcluZr2Nqb9PkBZ1sQG3tFWQONQddb4Cl8KEY">
    <span style="font-family: 'Calibri',sans-serif;">
     Creative
 Commons Attribution License
    </span>
   </a>
   <span style="font-family: 'Calibri',sans-serif;">
    , which permits free reuse of all materials published with the article, so long as the work is cited.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <strong>
    <span style="font-family: 'Calibri',sans-serif;">
     About the Public Library of Science
    </span>
   </strong>
   <span style="font-family: 'Calibri',sans-serif;">
    <br/>
    Public Library of Science (PLOS) is a nonprofit Open Access (OA) publisher, innovator and advocacy organization dedicated to accelerating progress in science and medicine by leading a transformation in research communication. The PLOS suite of journals contain
 rigorously peer-reviewed Open Access research articles from all areas of science and medicine, together with expert commentary and analysis. In addition to journals, the organization advances innovations in scientific publishing through Collections, Communities
 and The PLOS Blog Network. Founded to catalyze a revolution in scientific publishing by demonstrating the value and feasibility of Open Access publication, PLOS is committed to innovative and forward-looking solutions to scientific communication. For more
 information, visit
   </span>
   <a style="color: blue; text-decoration: underline;" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=https%3A%2F%2Fwww.plos.org%2Fwho-we-are&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=BqOSi3ppOyv3Csnw0_v_icvsFn3i04AZXukktmEDzM4">
    <span style="font-family: 'Calibri',sans-serif;">
     https://www.plos.org/who-we-are
    </span>
   </a>
   .
   <span style="font-family: 'Calibri',sans-serif;">
    <br/>
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <strong>
    <span style="font-family: 'Calibri',sans-serif;">
     ­­Disclaimer
    </span>
   </strong>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
    This press release refers to upcoming articles in
    <em>
     PLOS Neglected Tropical Diseases
    </em>
    . The releases have been provided by the article authors and/or journal staff. Any opinions expressed are the personal views of the contributors, and do not necessarily represent the views or policies of PLOS. PLOS expressly
 disclaims any and all warranties and liability in connection with the information found in the release and article and your use of such information.
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <a href="#_top">
    Back to the Top
   </a>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <p style="margin: 0in 0in 0.0001pt; font-size: 12pt; font-family: 'Times New Roman', serif;">
   <span style="font-family: 'Calibri',sans-serif;">
   </span>
  </p>
  <br/>
  <br/>
  <p style="text-align:center; clear:both;">
   <span class="sl-translate">
    This email was sent to newsdesk@sciencemediacenter.de
   </span>
   <br/>
   <span>
    PLOS, 1160 Battery Street, Suite 100, San Francisco, California 94111, United States
   </span>
   <br/>
   <a class="sl-translate" href="http://link.email.dynect.net/link.php?DynEngagement=true&H=VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D&G=0&R=https%3A%2F%2Finfluencers.meltwater.com%2Funsubscribe%2FICM%3Fc%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%26iv%3D9ec778c5bffc714a9aecc01ccfa92156&I=20170206213409.000004b506c0%40mail6-21-ewr&X=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D&S=2D4IHzEoEeHa6u3G-2uNVUAYN6Hg0LA_Yvnei8f_y34">
    Unsubscribe
   </a>
  </p>
  <img src="http://trk.email.dynect.net/trk.php?a=/o2/0/VKAA6jcjimpH7GQU6c%2BJ03eoe12AiHWJKDSwnz%2Bngl0%2BSYpE0NWtuFT74s%2FpZxhOohAJCSt7gn8CDDaqi8LoSlYriDtcdJuW%2Bxo%2Fiyr3HUQjodCrRHVdkg%3D%3D/i.gif&i=20170206213409.000004b506c0%40mail6-21-ewr&x=MHwxMDQ2NzU4OjU4OThkMjU3Nzg0ODQ4ZmE4YzZlNjNiMjs%3D" alt="" width="2" height="2"/>
 </body>
</html>
